In conversation with Ankit Kankar, General Manager at BioSpectrum Asia, Alexander Seyf, CEO and co found...
In his keynote session, Heath Coats shared practical regulatory insights drawn from his experience both ...
Israel-based Evogene has announced a collaboration with the pioneering research group of Dr Mark Adams, a leading c...
US-based BostonGene, the developer of the leading AI foundation model for tumour and immune biology, has announced ...
Galux, a South Korea-based biotech startup pioneering artificial intelligence (AI)-driven protein therapeutics design, h...
Swiss firm SpiroChem AG and Japan-based Veritas In Silico Inc. have announced the signing of a Memorandum of Understandi...
Pierre Fabre Laboratories and Iktos, a global leader in Artificial Intelligence (AI) and Robotics on drug discovery, ann...
Iktos, a leader in Artificial Intelligence (AI) and Robotics applied to drug discovery, announced a landmark multi-targe...
Hong Kong headquartered Insilico Medicine, a leading artificial intelligence (AI)-driven drug discovery company, has ann...
Japan-based Meiji Seika Pharma has entered into a partnership agreement with MBC BioLabs which is a private organisation...
At an AbbVie-sponsored symposium at the ESMO Asia Congress 2025, experts gathered to address platinum resistance in adva...
US-based BostonGene, developer of the leading AI foundation model for cancer and the immune system, and Kyoto ...
Hong Kong-based Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery compan...
Harbour BioMed, a global biopharmaceutical company committed to the discovery and development of novel antibod...
Japan's Chugai Pharmaceutical and US-based Rani Therapeutics, LLC, a subsidiary of Rani Therapeutics Holdings, Inc., hav...
Nanyang Biologics (NYB) has entered into a business combination agreement (BCA) with RF Acquisition Corp II (RFAI), a pu...
Japanese pharmaceutical firm Daiichi Sankyo has established Daiichi Sankyo Research Institute in San Diego, US represent...
Merck and Siemens have signed a new Memorandum of Understanding (MoU), extending their strategic partnership to accelera...
Nanyang Biologics (NYB) enters a strategic collaboration with NVIDIA, Hewlett Packard Enterprise (HPE), and Equinix to b...
ProBio, a leading contract development and manufacturing organization (CDMO) specializing in gene and cell therapy, ...
XtalPi, a China-based technology company in integrating artificial intelligence (AI) and robotics for drug and materials...
Japan-based Astellas Pharma Inc. has agreed on a Memorandum of Understanding (MoU) with the Korea Institute of Star...
BioSpectrum Asia spoke to Dr Peter Fedichev, CEO of Gero, who explains how ProtoBind-Diff is transforming drug discovery...
South Korea-based SK Biopharm has signed a strategic Memorandum of Understanding (MoU) with AI corporation PhnyX Lab in ...
Nuclera, a UK-based biotechnology company accelerating protein expression and optimisation through its benchtop eProtein...
